Abbott Stock Screener | Share Price & Fundamental Analysis

Share Price NSE
₹26295.00
▼ -100.00 (-0.38%)
2026-02-20 00:00:00
Share Price BSE
₹26263.35
▼ -126.10 (-0.48%)
2026-02-20 00:00:00
Track Abbott share price live with TickJournal's free stock screener. Analyze Abbott share price history trends and compare 52-week high low levels. Calculate ABBOTINDIA stock fair value using fundamental analysis and view live share price charts. Determine Abbott share intrinsic value and compare it with current ABBOTINDIA share price. Record your Abbott trades in TickJournal's free trading journal and track your portfolio performance.
Abbott Market Cap ₹56,225.65 Cr.
EPS (TTM) ₹665.62
Dividend Yield 1.78%
Debt to Equity 0.04
Abbott 52 Week Low ₹26290.00
Operating Margin 27.00%
Profit Margin 21.43%
EBITDA ₹2,128.00
Net Income ₹1,524.00
Total Assets ₹5,917.00
Total Equity ₹4,233.00

Abbott Share Price History - Stock Screener Chart

Screen ABBOTINDIA historical share price movements with interactive charts. Analyze price trends and patterns.

Abbott Company Profile - Fundamental Screener

Screen Abbott company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ABBOTINDIA shares.
Abbott India Ltd is a leading multinational pharmaceutical company in India. It operates an owned manufacturing facility in Goa and works with various independent contract manufacturers across the country. The company sells its products primarily within India through independent distributors. Abbott India provides pharmaceutical products and solutions across various therapeutic...more
Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E
Chairperson/CEO Munir Shaikh
ISIN INE358A01014

Abbott Balance Sheet Screener

Screen ABBOTINDIA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Assets
Total Assets 5,917 5,194 4,556 4,224 3,840 3,547 2,941 2,416 2,066 1,617
Current Assets 4,742 3,246 3,025 3,853 3,487 3,205 2,761 2,266 1,893 1,451
Fixed Assets 336 225 237 271 251 270 105 81 110 109
Liabilities
Total Liabilities 5,917 5,194 4,556 4,224 3,840 3,547 2,941 2,416 2,066 1,617
Current Liabilities 277 152 161 201 207 224 75 55 47 39
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0
Shareholders' Equity
Total Equity 4,233 3,699 3,189 2,820 2,602 2,432 2,009 1,693 1,387 1,196
Share Capital 21 21 21 21 21 21 21 21 21 21
Reserves & Surplus 4,212 3,678 3,167 2,799 2,581 2,411 1,987 1,672 1,366 1,174

Abbott Income Statement Screener - Profit & Revenue Analysis

Screen Abbott income statement and profit fundamentals. Analyze ABBOTINDIA quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Abbott share price evaluation.
Item None-None 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March
Revenue 7,113 6,685 6,097 5,503 4,997 4,391 4,208 3,792 3,416 2,960 2,665 2,337
Expenses 4,985 4,715 4,396 4,143 3,832 3,389 3,337 3,074 2,774 2,505 2,250 1,977
EBITDA 2,128 1,970 1,701 1,360 1,165 1,002 871 718 642 455 415 360
Operating Profit % 27.00% 26.00% 25.00% 23.00% 22.00% 21.00% 18.00% 16.00% 16.00% 14.00% 14.00% 13.00%
Depreciation 75 72 71 70 66 58 60 17 16 16 14 15
Interest 23 11 12 16 19 18 9 2 4 2 3 1
Profit Before Tax 2,031 1,887 1,618 1,274 1,080 926 803 699 622 437 398 344
Tax 522 473 417 324 281 235 210 249 220 160 143 115
Net Profit 1,524 1,414 1,201 949 799 691 593 450 401 277 255 229
EPS 717.20 665.62 565.28 446.80 375.87 325.04 279.04 211.93 188.81 130.19 120.12 107.75

Abbott Cash Flow Screener - Liquidity Fundamentals

Screen ABBOTINDIA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March
Operating Activities 1,012 1,213 893 948 727 626 499 153 307 249
Investing Activities 182 -416 -148 -396 -72 -401 -257 -215 -155 -77
Financing Activities -925 -745 -639 -637 -582 -217 -143 -102 -90 -80
Net Cash Flow 269 52 107 -86 73 8 99 -165 62 91

Abbott Shareholding Pattern Screener

See Abbott shareholding pattern with promoter, FII, and DII holdings. Check Abbott promoter holding and ownership changes for ABBOTINDIA on TickJournal.
Item 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec
Promoter Holding 74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99%
FII Holding 0.16% 0.16% 0.16% 0.18% 0.18% 0.18% 0.16% 0.16%
DII Holding 8.92% 9.19% 9.11% 9.00% 8.91% 8.81% 8.99% 9.01%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 13.66% 13.35% 13.43% 13.42% 13.80% 13.86% 13.65% 13.59%
Other Holding 2.28% 2.31% 2.31% 2.42% 2.12% 2.16% 2.21% 2.25%
Shareholder Count 69,934 67,584 71,199 75,801 69,382 71,588 69,449 67,892

Abbott Share Dividend Screener - Share Yield Analysis

Check Abbott dividend history with payout and yield data. View Abbott dividend details including ex-dates and amounts for ABBOTINDIA stock.
Period Dividend Per Share Dividend Yield
2026-March ₹0.00 0.00%
2025-March ₹475.00 1.80%
2024-March ₹410.00 1.33%
2023-March ₹325.00 1.20%
2022-March ₹275.00 1.26%
2021-March ₹275.00 1.55%
2020-March ₹250.00 1.67%
2019-March ₹65.00 0.42%
2018-March ₹55.00 0.75%
2017-March ₹40.00 0.73%

Abbott Market Events Screener - Corporate Actions

Get Abbott corporate actions including splits, bonuses, and buybacks. Check Abbott stock events that may affect ABBOTINDIA share price.
Announcement Date Record Date Event Type Information Price Impact
2026-02-12 2026-02-12 Quarterly Result Announcement NA 0.09%
2025-11-06 2025-11-06 Quarterly Result Announcement NA -1.36%
2025-08-13 2025-08-13 Annual General Meeting NA 6.57%
2025-08-12 2025-08-12 Quarterly Result Announcement NA -1.83%
2025-07-25 2025-07-25 Dividend ₹ 475.00 /share 13.94%
2025-05-15 2025-05-15 Quarterly Result Announcement NA 0.67%
2025-02-05 2025-02-05 Quarterly Result Announcement NA -1.42%
2024-11-07 2024-11-07 Quarterly Result Announcement NA 2.06%
2024-08-08 2024-08-08 Annual General Meeting NA 8.45%
2024-07-19 2024-07-19 Dividend ₹ 410.00 /share 10.98%
2023-07-21 2023-07-21 Dividend ₹ 180.00 /share 12.85%
2023-07-21 2023-07-21 Dividend ₹ 145.00 /share 12.85%
2022-08-02 2022-08-04 Dividend ₹ 130.00 /share 24.76%
2022-08-02 2022-08-04 Dividend ₹ 145.00 /share 24.76%
2021-07-19 2021-07-21 Dividend ₹ 120.00 /share 7.42%

Abbott Competitors Screener - Peer Comparison

Screen ABBOTINDIA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 407,287 37.56 54,729 9.71% 10,980 52.49
Divis Laboratories 163,754 66.27 9,712 18.67% 2,191 48.87
Torrent Pharmaceuticals 138,018 64.55 11,539 6.99% 1,911 59.36
Cipla 107,555 23.69 28,410 7.12% 5,291 35.86
Dr Reddys Laboratories 105,839 19.26 33,741 16.73% 5,725 58.24
Lupin 100,464 23.23 22,910 13.74% 3,306 56.93
Zydus Life Science 91,034 18.43 23,511 18.55% 4,615 51.32
Mankind Pharma 85,058 47.59 12,744 20.90% 2,007 42.02
Aurobindo Pharma 66,537 19.29 32,346 9.43% 3,484 45.13
Alkem Laboratories 64,595 29.06 13,458 3.70% 2,216 36.02

Abbott Company Announcements - News Screener

Screen ABBOTINDIA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2026-02-21 Announcement under Regulation 30 (LODR)-Newspaper Publication View
2026-02-20 Unaudited Financial Results Of The Company For The Quarter Ended December 31 2025. View
2026-02-20 Board Meeting Outcome for Outcome Of Board Meeting. View
2026-02-12 Announcement under Regulation 30 (LODR)-Newspaper Publication View
2026-02-12 Board Meeting Intimation for Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025. View
2026-01-14 Announcement under Regulation 30 (LODR)-Newspaper Publication View
2026-01-14 Shareholder Meeting / Postal Ballot-Notice of Postal Ballot View
2026-01-08 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 View
2025-12-31 Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015. View
2025-12-24 Announcement under Regulation 30 (LODR)-Change in Directorate View
2025-12-19 Closure of Trading Window View
2025-11-25 Announcement under Regulation 30 (LODR)-Change in Management View
2025-11-24 Approval Of Central Government For Appointment Of Managing Director View
2025-11-07 Announcement under Regulation 30 (LODR)-Newspaper Publication View
2025-11-06 Unaudited Financial Results For The Quarter Ended September 30 2025. View
2025-11-06 Board Meeting Outcome for Outcome Of Board Meeting View
2025-10-29 Board Meeting Intimation for Intimation Under Regulation 29(1)(A) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015. View
2025-10-15 Shareholder Meeting / Postal Ballot-Scrutinizer"s Report View
2025-10-13 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 View
2025-10-08 Announcement under Regulation 30 (LODR)-Change in Management View